Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Switzerland
MedTech
Ypsomed sells diabetes business to focus on GLP-1 self-injectors
Ypsomed plans to trade its insulin pump arm to a new Swiss medtech, TecMed, in a deal worth up to 420 million francs or about $513 million.
Conor Hale
Apr 23, 2025 6:20am
Idorsia's Tryvio sale behind schedule, but layoffs on track
Dec 20, 2024 4:42am
Roche ramps up R&D with new high-rise labs
Sep 11, 2024 10:40am
South Korean biotech group spies US SPAC as route to Nasdaq
Jul 12, 2023 8:45am
BC Platforms acquires CRO 4Pharma for undisclosed price
Jun 14, 2023 4:05pm
Spexis narrows focus to keep lights on into 2023
Jul 28, 2022 8:45am
